In this section, we will briefly introduce the pathology of glioma and summarize the implication of the blood–brain interfaces in drug resistance, particularly the role of ABC transporters, and some strategies to study and improve anticancer drug transport and delivery. The gene discussed is ABCG2; the disease is central nervous system cancer.